June 25, 2019
-Approval Based on Positive Efficacy and Safety Data from Two Phase 3 Clinical Trials-
-Company Intends to Partner for the European Commercialization of DOPTELETDURHAM, N.C., June 25, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA), a pharmaceutical company focused on acquiring, developing and commercializing drug candidates for diseases where there is a high unmet need,

First Meeting of the Nottinghamshire ITP Support Group

The first meeting of the Nottinghamshire ITP Support Group took place recently in Chichester, details of the next meeting are available at Local Support Group Meetings

First Meeting of the West Sussex ITP Support Group

The first meeting of the West Sussex ITP Support Group took place recently in Chichester, details of the next meeting are available at Local Support Group Meetings

First Meeting of the North West ITP Support Group

The first meeting of the North West ITP Support Group took place recently in Alderley Edge, details of the next meeting are available at Local Support Group Meetings

First Local ITP Group Meeting in Devon

We recently held the first Local ITP Group Meeting of the year. The meeting was held in the Ancient Stannary Town of Ashburton in the heart of the South Devon countryside, close to the edge of Dartmoor. We must say a big thankyou to member of the ITP Support Association, Sally Rhodes, who stepped forward and volunteered to organise a suitable venue for the meeting.

ITP Partnership Prospectus Published

We are also pleased to announce the publication of the ITP Support Associations Partnership Prospectus for 2019/20. This document helps to explain the tremendous reach of the Association (the only National ITP Patient Support Charity) and opportunities that are available for collaboration with potential partners such as sponsorship for items such as the Website, Platelet newsletter and our Booklets. In addition, there are opportunities for partners to work with us at events such as our Annual Convention.

 ITP Pocket Log - looking for ideas for Version 2

At the recent ITP Convention, Mervyn Morgan made a short presentation about the ITP Pocket Log and the progress that has been made since its launch in 2017. Since the app went live there have been over 400 downloads plus some excellent feedback.

We are now looking to ITP Pocket Log Version 2, so if anyone has any ideas of features, they would like to see in version 2 please email your ideas to This email address is being protected from spambots. You need JavaScript enabled to view it..

NICE have published their review of TPO-RA and have updated their approval for Romiplostim and Eltrombopag

Romiplostim is recommended as an option for treating chronic immune (idiopathic) thrombocytopenic purpura in adults, only if: